山東威高集團醫用高分子製品股份有限公司（01066）於2025年11月27日發布翌日披露報表。公告顯示，公司於同日回購42萬股H股，約佔該次交易前已發行股份總數的0.0093%，每股價格介乎每股5.50港元至5.64港元，總涉資約233.5萬港元。
經此交易後，公司於2025年11月27日的已發行股份（不包括庫藏股）數目為4,495,216,324股，庫藏股數目增至27,116,000股，合計仍維持4,522,332,324股。購回授權於2025年5月27日獲通過，目前公司已根據該授權累計回購20,467,600股，約佔當日已發行股份總數的4.5326%。
公司在公告中確認，上述股份回購及有關程序均遵守香港聯合交易所有限公司證券上市規則及相關法例。公告由公司秘書黃妙玲簽署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.